Cargando…

The Potential Therapeutic Role of Metformin in Diabetic and Non-Diabetic Bone Impairment

Metformin is a widely-used anti-diabetic drug in patients with type 2 diabetic mellitus (T2DM) due to its safety and efficacy in clinical. The classic effect of metformin on lowering blood glucose levels is to inhibit liver gluconeogenesis that reduces glucose production as well as increases periphe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Wei, Liang, Guoqiang, Feng, Yue, Jiang, Yunyun, Qu, Falin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611301/ https://www.ncbi.nlm.nih.gov/pubmed/36297386 http://dx.doi.org/10.3390/ph15101274

Ejemplares similares

Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes
por: Dutta, Siddhartha, et al.
Publicado: (2023)

Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
por: Hostalek, Ulrike, et al.
Publicado: (2015)

A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
por: Geagea, Alice Gerges, et al.
Publicado: (2019)

Potential Enhancement of Metformin Hydrochloride in Lipid Vesicles Targeting Therapeutic Efficacy in Diabetic Treatment
por: Ossai, Emmanuel Chekwube, et al.
Publicado: (2021)

Therapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes
por: Insin, Putsarat, et al.
Publicado: (2018)

Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
por: Moore, Eileen M., et al.
Publicado: (2013)

Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans
por: Rotroff, Daniel M., et al.
Publicado: (2016)

Correction: A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
por: Geagea, Alice Gerges, et al.
Publicado: (2019)

Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin
por: Bailey, Clifford J., et al.
Publicado: (2022)

Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes
por: Kondo, Masaki, et al.
Publicado: (2015)

Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes
por: Jiating, Lin, et al.
Publicado: (2019)

Metformin regulates bone marrow stromal cells to accelerate bone healing in diabetic mice
por: Guo, Yuqi, et al.
Publicado: (2023)

Role of metformin in epigenetic regulation of placental mitochondrial biogenesis in maternal diabetes
por: Jiang, Shaoning, et al.
Publicado: (2020)

The Therapeutic Potential of Metformin in Neurodegenerative Diseases
por: Rotermund, Carola, et al.
Publicado: (2018)

From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
por: Ouyang, Jing, et al.
Publicado: (2020)

The Effect of Metformin in Diabetic and Non-Diabetic Rats with Experimentally-Induced Chronic Kidney Disease
por: Za’abi, Mohammed Al, et al.
Publicado: (2021)

Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role
por: Samuel, Samson Mathews, et al.
Publicado: (2021)

A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 2013;36:2981–2987
por: Moore, EM, et al.
Publicado: (2013)

Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2022)

Metformin in Gestational Diabetes Mellitus
por: Reece, Sara Wilson, et al.
Publicado: (2014)

Metformin in gestational diabetes mellitus
por: Tripathi, Reva, et al.
Publicado: (2017)

Editorial: Metformin: Beyond Diabetes
por: Bost, Frédéric, et al.
Publicado: (2019)

Metformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen Disposal
por: Li, Xiyan, et al.
Publicado: (2015)

The Role of Metformin in Controlling Oxidative Stress in Muscle of Diabetic Rats
por: Diniz Vilela, Danielle, et al.
Publicado: (2016)

Metformin in COVID-19: A possible role beyond diabetes
por: Sharma, Swati, et al.
Publicado: (2020)

Variability in the therapeutic response of Metformin treatment in patients with type 2 diabetes mellitus
por: Rashid, Maryam, et al.
Publicado: (2019)

Therapeutic Applications of Type 2 Diabetes Mellitus Drug Metformin in Patients with Osteoarthritis
por: Song, Parkyong, et al.
Publicado: (2021)

Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
por: Forouzandeh, Farshad, et al.
Publicado: (2014)

Diabetic Bone Disease and Diabetic Myopathy: Manifestations of the Impaired Muscle-Bone Unit in Type 1 Diabetes
por: Travis, Callie, et al.
Publicado: (2022)

Potential of Metformin to Improve Cardiac Risk in Postpartum Women with Gestational Diabetes
por: Viteri, Oscar A., et al.
Publicado: (2017)

Metformin: A Potential Therapeutic Tool for Rheumatologists
por: Salvatore, Teresa, et al.
Publicado: (2020)

Bone-kidney axis: A potential therapeutic target for diabetic nephropathy
por: Yang, Ming, et al.
Publicado: (2022)

Comparative evaluation of the therapeutic effect of metformin monotherapy with metformin and acupuncture combined therapy on weight loss and insulin sensitivity in diabetic patients
por: Firouzjaei, A, et al.
Publicado: (2016)

Bone Morphogenetic Protein-4 Impairs Retinal Endothelial Cell Barrier, a Potential Role in Diabetic Retinopathy
por: Darwish, Noureldien H. E., et al.
Publicado: (2023)

Metformin Reduces Potassium Currents and Prolongs Repolarization in Non-Diabetic Heart
por: Malagueta-Vieira, Layse, et al.
Publicado: (2022)

Comparison of Beinaglutide Versus Metformin for Weight Loss in Overweight and Obese Non-diabetic Patients
por: Gao, Lijun, et al.
Publicado: (2021)

Long-Term Effectiveness and Cost-Effectiveness of Metformin Combined with Liraglutide or Exenatide for Type 2 Diabetes Mellitus Based on the CORE Diabetes Model Study
por: Zhang, Xuesong, et al.
Publicado: (2016)

The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing
por: Jeyabalan, J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1no6j76nstegam0j73r79u7htq